Header cover image

Canadian (TSX) Pharma Industry Analysis

UpdatedJun 08, 2023
DataAggregated Company Financials
Companies121
  • 7D-1.1%
  • 3M-21.8%
  • 1Y-54.3%
  • YTD-26.5%

The Pharma industry is down 4.8% over the last week with Green Thumb Industries the worst performer, down 5.5%. In contrast, iAnthus Capital Holdings has gained 20%. However, the industry is down 56% over the past year. Looking forward, earnings are forecast to grow by 78% annually.

Industry Valuation and Performance

Has the Canadian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 08 Jun 2023CA$14.6bCA$13.3b-CA$10,398,674,708.0010.3x-1.4x1.1x
Sat, 06 May 2023CA$16.5bCA$13.3b-CA$10,297,242,673.0011.1x-1.6x1.2x
Mon, 03 Apr 2023CA$16.3bCA$13.4b-CA$10,036,187,625.008.7x-1.6x1.2x
Wed, 01 Mar 2023CA$19.3bCA$13.7b-CA$10,254,161,221.009.8x-1.9x1.4x
Fri, 27 Jan 2023CA$19.0bCA$13.5b-CA$10,087,001,268.0014.4x-1.9x1.4x
Sun, 25 Dec 2022CA$20.0bCA$13.6b-CA$10,151,710,113.0012.4x-2x1.5x
Tue, 22 Nov 2022CA$29.1bCA$13.5b-CA$10,230,610,337.0010.4x-2.8x2.2x
Thu, 20 Oct 2022CA$27.7bCA$13.5b-CA$9,430,518,444.0011.4x-2.9x2.1x
Sat, 17 Sep 2022CA$28.4bCA$13.1b-CA$8,843,772,737.0013.8x-3.2x2.2x
Mon, 15 Aug 2022CA$29.3bCA$12.5b-CA$8,212,978,013.0013.2x-3.6x2.3x
Wed, 13 Jul 2022CA$26.0bCA$12.2b-CA$5,775,145,638.0010.4x-4.5x2.1x
Fri, 10 Jun 2022CA$30.4bCA$12.2b-CA$5,480,470,272.009.9x-5.5x2.5x
Sun, 08 May 2022CA$34.6bCA$12.0b-CA$4,925,777,728.0011.6x-7x2.9x
Tue, 05 Apr 2022CA$44.6bCA$11.6b-CA$4,640,383,890.0013.3x-9.6x3.8x
Thu, 03 Mar 2022CA$42.5bCA$10.6b-CA$4,454,287,976.0013.5x-9.5x4x
Sat, 29 Jan 2022CA$44.4bCA$10.9b-CA$4,933,422,632.0011.6x-9x4.1x
Mon, 27 Dec 2021CA$54.9bCA$10.9b-CA$4,964,997,894.0013.5x-11.1x5x
Wed, 24 Nov 2021CA$65.1bCA$10.8b-CA$4,877,103,503.0019.6x-13.3x6x
Fri, 22 Oct 2021CA$63.7bCA$10.1b-CA$4,883,044,951.0019.2x-13x6.3x
Sun, 19 Sep 2021CA$66.8bCA$10.4b-CA$6,658,476,418.0021.4x-10x6.4x
Tue, 17 Aug 2021CA$69.0bCA$10.2b-CA$6,616,236,433.2722.3x-10.4x6.8x
Tue, 01 Jun 2021CA$81.6bCA$8.9b-CA$7,509,828,145.2124.4x-10.9x9.2x
Fri, 05 Mar 2021CA$92.2bCA$7.6b-CA$8,166,561,132.2744.4x-11.3x12.2x
Mon, 07 Dec 2020CA$59.6bCA$6.6b-CA$10,071,038,851.7626.4x-5.9x9.1x
Thu, 10 Sep 2020CA$41.1bCA$5.6b-CA$8,989,610,861.7923.1x-4.6x7.4x
Price to Earnings Ratio

-3.8x


Total Market Cap: CA$33.7bTotal Earnings: -CA$8,871,002,112.22Total Revenue: CA$5.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Pharma Industry Price to Earnings3Y Average -6.8x202120222023
Current Industry PE
  • Investors are pessimistic on the Canadian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 5.2x is higher than the industry's current PS ratio of 1.1x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 34% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Canadian Pharma compare with similar industries?

CA Market2.01%
Healthcare0.52%
Pharma-1.14%
Pharma-1.14%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CURA Curaleaf HoldingsCA$4.054.7%
+CA$129.4m
-46.3%PS1.6x
IAN iAnthus Capital HoldingsCA$0.0320.0%
+CA$32.2m
-66.7%PS0.9x
GSD Devonian Health GroupCA$0.2852.8%
+CA$15.2m
-54.2%PS18x
GUD Knight TherapeuticsCA$4.932.7%
+CA$14.2m
-7.0%PS1.7x
OGI Organigram HoldingsCA$0.557.8%
+CA$12.9m
-61.3%PS1.1x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

PCLO

CA$0.23

PharmaCielo

7D

27.8%

1Y

-53.1%

ACB

CA$0.70

Aurora Cannabis

7D

2.9%

1Y

-64.5%

LOVE

CA$0.96

Cannara Biotech

7D

-13.5%

1Y

-12.7%

TRUL

CA$5.48

Trulieve Cannabis

7D

-5.0%

1Y

-69.0%

CL

CA$2.20

Cresco Labs

7D

-3.5%

1Y

-49.0%

AYR.A

CA$1.15

Ayr Wellness

7D

-14.8%

1Y

-85.0%

WEED

CA$0.98

Canopy Growth

7D

-13.3%

1Y

-81.1%

GUD

CA$4.93

Knight Therapeutics

7D

2.7%

1Y

-7.0%

TER

CA$2.16

TerrAscend

7D

-2.7%

1Y

-52.0%

GSD

CA$0.28

Devonian Health Group

7D

52.8%

1Y

-54.2%

CRON

CA$2.30

Cronos Group

7D

-4.2%

1Y

-37.2%

IAN

CA$0.03

iAnthus Capital Holdings

7D

20.0%

1Y

-66.7%

OGI

CA$0.55

Organigram Holdings

7D

7.8%

1Y

-61.3%